首页 | 本学科首页   官方微博 | 高级检索  
     

美常安联合柳氮磺吡治疗溃疡性结肠炎22例
引用本文:向军英,冯迎春. 美常安联合柳氮磺吡治疗溃疡性结肠炎22例[J]. 世界华人消化杂志, 2006, 14(17): 1742-1744
作者姓名:向军英  冯迎春
作者单位:川北医学院附属医院消化内科,四川省,南充市,637000
摘    要:

关 键 词:溃疡性结肠炎  美常安  治疗
收稿时间:2005-10-25
修稿时间:2005-10-25

Therapeutic effect of Medilac-S combined with sulfasalazine in treatment of ulcerative colitis: an analysis of 22 cases
Jun-Ying Xiang,Ying-Chun Feng. Therapeutic effect of Medilac-S combined with sulfasalazine in treatment of ulcerative colitis: an analysis of 22 cases[J]. World Chinese Journal of Digestology, 2006, 14(17): 1742-1744
Authors:Jun-Ying Xiang  Ying-Chun Feng
Abstract:AIM: To evaluate the therapeutic effect of Medilac-S combined with sulfasalazine (SASP) in the treatment of ulcerative colitis (UC). METHODS: Forty-six patients with mild or moderate UC (active phase) were divided into group A (n = 22) and B (n = 24). The patients in group A were treated with Medilac-S and SASP, while those in group B, serving as the controls, were treated with SASP. The total efficacy rate and the changes of main symptoms were statistically analyzed. RESULTS: The overall efficacy of group A was 91.66%, which was higher than that of the controls (68.18%, P < 0.05). There was significant difference before and after treatment, as well as between the two groups (P < 0.05) in the changes of abdominal pain, diarrhea, mucus bloody stool and tenesmus (P < 0.05). CONCLUSION: Combination of Medilac-S and SASP is superior to SASP alone in the treatment of UC
Keywords:Ulcerative Colitis  Medilac-S  Treatment
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《世界华人消化杂志》浏览原始摘要信息
点击此处可从《世界华人消化杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号